News
July 17, 2024
AbTherx Appoints Pallavi Tawde, PhD, as Head of Preclinical R&D...
Former Pfizer, BMS, and Denali scientific leader to lead expansion of antibody discovery, preclinical development, and early clinical capabilities Foster City, Calif.... Read More »
June 18, 2024
AbTherx Opens Antibody Discovery Technologies Research Center
New research center’s world-class antibody discovery capabilities support a growing portfolio of Atlas™ Mice transgenic technologies and partnerships Foster City, Cal... Read More »
May 9, 2024
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic...
Bar Harbor, Maine and Mountain View, California – May 9, 2024 – The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx,... Read More »
March 20, 2024
AbTherx Appoints Jessica Stark, PhD, as Scientific Advisor
Glycoimmunology expert and co-inventor of AbLec technology joins AbTherx to expand expertise around challenging drug targets Mountain View, Calif. – March 20, 2024 – ... Read More »
March 13, 2024
AbTherx Partners with Single Cell Technology for First Antibody Discovery...
Partnership provides AbTherx and licensees of AbTherx’s Atlas™ Mice access to Single Cell Technology’s proprietary single B cell screening engine Mountain View ... Read More »
